批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/12/15 |
SUPPL-54(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/08/08 |
SUPPL-45(补充) |
Tentative Approval |
Manufacturing (CMC) |
N/A
|
|
|
2022/04/12 |
SUPPL-52(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/10/07 |
SUPPL-43(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/01/24 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/12/16 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/05/18 |
SUPPL-37(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/07/03 |
SUPPL-34(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/10/17 |
SUPPL-32(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/04/26 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1995/02/22 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1993/12/23 |
SUPPL-29(补充) |
Approval |
Labeling |
|
|
|
1993/12/23 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1993/12/23 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1993/12/23 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1992/12/07 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1992/10/28 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1991/11/25 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1990/07/05 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1989/09/14 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1987/01/27 |
SUPPL-20(补充) |
Approval |
Labeling |
|
|
|
1986/09/05 |
SUPPL-19(补充) |
Approval |
Labeling |
|
|
|
1986/09/05 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1985/09/10 |
SUPPL-17(补充) |
Approval |
Labeling |
|
|
|
1983/09/07 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1983/03/11 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1982/07/07 |
SUPPL-12(补充) |
Approval |
Labeling |
|
|
|
1982/07/07 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1981/02/24 |
SUPPL-10(补充) |
Approval |
Labeling |
|
|
|
1981/02/24 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1980/05/23 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1976/11/08 |
SUPPL-4(补充) |
Approval |
Labeling |
|
|
|
1968/02/19 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:FENTANYL CITRATE 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 0.05MG BASE/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
016619 |
001 |
NDA |
SUBLIMAZE PRESERVATIVE FREE |
FENTANYL CITRATE |
INJECTABLE;INJECTION |
EQ 0.05MG BASE/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
RISING |
019101 |
001 |
NDA |
FENTANYL CITRATE |
FENTANYL CITRATE |
INJECTABLE;INJECTION |
EQ 0.05MG BASE/ML |
Prescription |
Yes |
Yes |
AP |
1984/07/11
|
HIKMA |
019115 |
001 |
NDA |
FENTANYL CITRATE |
FENTANYL CITRATE |
INJECTABLE;INJECTION |
EQ 0.05MG BASE/ML |
Prescription |
No |
No |
AP |
1985/01/12
|
HOSPIRA |
072786 |
001 |
ANDA |
FENTANYL CITRATE PRESERVATIVE FREE |
FENTANYL CITRATE |
INJECTABLE;INJECTION |
EQ 0.05MG BASE/ML |
Prescription |
No |
No |
AP |
1991/09/24
|
HOSPIRA |
210762 |
001 |
ANDA |
FENTANYL CITRATE PRESERVATIVE FREE |
FENTANYL CITRATE |
INJECTABLE;INJECTION |
EQ 0.05MG BASE/ML |
Prescription |
No |
No |
AP |
2019/05/03
|
FRESENIUS KABI USA |
212086 |
001 |
ANDA |
FENTANYL CITRATE |
FENTANYL CITRATE |
INJECTABLE;INJECTION |
EQ 0.05MG BASE/ML |
Prescription |
No |
No |
AP |
2020/09/01
|
FRESENIUS KABI USA |